C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2715319
Methods and compositions are provided to determine if a cancer is resistant to treatment with anti-mitotic agents, including treatment with T-DM 1. The methods relate to determining if the ABCC3 gene is amplified and/or overexpressed in the cancer.
La présente invention concerne des procédés et des compositions pour déterminer si un cancer est résistant à un traitement par des agents antimitotiques, et notamment à un traitement par du T-DM1. Les procédés consistent à déterminer si le gène ABCC3 est amplifié et/ou surexprimé dans le cancer.
Amler Lukas C.
Cavet Guy
Lackner Mark
O'brien Carol
Pandita Ajay
Genentech Inc.
Smart & Biggar
LandOfFree
Genetic variations associated with drug resistance does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetic variations associated with drug resistance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic variations associated with drug resistance will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2033119